Efficacy of endostar in combination with concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of esophagus: A randomized, open-label, phase II trial

被引：0

作者：

Qi, Y. ^{[1
]}

Shao, L. ^{[1
]}

机构：

[1] Sun Yat Sen Univ, Radiat, Canc Ctr, Gansu Hosp, Lanzhou, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.10.778

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

199P

引用

页码：S1551 / S1551

页数：1

共 50 条

[1] Phase II trial of endostar in combination with concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of esophagus
Qi, Y.
Wei, S.
Shao, L.
ANNALS OF ONCOLOGY, 2023, 34 : S867 - S867
[2] The Efficacy and Safety of Continuous Intravenous Endostar Treatment Combined With Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: A Randomized Controlled Trial
Shu, Hang
Dong, Yaqin
Xu, Zhonghua
Luo, Weiwei
Xu, Lei
Zhu, Haochen
Cheng, Linghui
Lv, Yin
FRONTIERS IN ONCOLOGY, 2021, 11
[3] Comparing toripalimab combined with chemoradiotherapy versus chemoradiotherapy alone for locally advanced esophageal squamous cell carcinoma: A multicenter, open-label, randomized phase II clinical trial
Xu, Yujin
Cheng, Qi
Wang, Yu
Zhu, Weiguo
Huang, Jing
Du, Dexi
Tian, Zhifeng
Yang, Haihua
Zhou, Chao
Zhou, Suna
Sun, Xiaojiang
Wang, Yuezhen
Wang, Jin
Wang, Zhun
Hu, Xiao
Chen, Ming
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[4] Camrelizumab in combination with chemotherapy versus concurrent chemoradiotherapy for the conversion of locally advanced unresectable oesophageal squamous carcinoma: protocol for a two-arm, open-label phase II trial
Chen, Maohui
Huang, Yizhou
Zhang, Shuliang
Zheng, Yixiong
Zeng, Taidui
Chen, Chun
Zheng, Bin
BMJ OPEN, 2024, 14 (02):
[5] A PHASE II TRIAL OF NIMOTUZUMAB IN COMBINATION WITH CHEMORADIOTHERAPY IN LOCALLY ADVANCED LUNG SQUAMOUS CELL CARCINOMA
Zhou, Lin
Liu, Jia
Liu, Rong-Mei
Gong, You-Ling
Zhang, Xin-Xing
Wang, Jin
Xu, Yong
Huang, Mei-Juan
Bai, Seng
Duan, Ping
Lu, You
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1572 - S1573
[6] An open label, multicenter clinical study of cetuximab combined with concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma Preliminary results of a phase II trial
Yu, J. M.
Wang, J. H.
Sun, X.
Wang, L. H.
Zhu, G. Y.
Feng, P. B.
Ye, M.
Lu, Y.
Zhu, S. C.
Liao, Z. X.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[7] Postoperative Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial
Li, Hui
Gu, Dayong
Du, Mingyu
Zhou, Guoren
Zhang, Zhi
Ye, Jinjun
FRONTIERS IN ONCOLOGY, 2022, 12
[8] Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
Yang, Hong
Liu, Hui
Chen, Yuping
Zhu, Chengchu
Fang, Wentao
Yu, Zhentao
Mao, Weimin
Xiang, Jiaqing
Han, Yongtao
Chen, Zhijian
Yang, Haihua
Wang, Jiaming
Pang, Qingsong
Zheng, Xiao
Yang, Huanjun
Li, Tao
Lordick, Florian
D'Journo, Xavier Benoit
Cerfolio, Robert J.
Korst, Robert J.
Novoa, Nuria M.
Swanson, Scott J.
Brunelli, Alessandro
Ismail, Mahmoud
Fernando, Hiran C.
Zhang, Xu
Li, Qun
Wang, Geng
Chen, Baofu
Mao, Teng
Kong, Min
Guo, Xufeng
Lin, Ting
Liu, Mengzhong
Fu, Jianhua
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (27) : 2796 - +
[9] Iparomlimab and tuvonralimab (QL1706) with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: An open-label phase II study
Zhang, W.
Zhang, T.
Chen, X.
Li, J.
Zheng, Z.
Dong, J.
Li, Z.
Zhao, G.
Cao, F.
Wang, P.
Yan, C.
Pang, Q.
ANNALS OF ONCOLOGY, 2024, 35 : S883 - S883
[10] Nimotuzumab in combination with preoperative concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: A prospective trial
Wu, Xiaoyuan
Chen, Yongshun
Yang, Yuanyuan
Hao, Daxuan
Li, Xue
He, Chunyu
Liu, Jinsong
Wang, Jianhua
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)

← 1 2 3 4 5 →